VePesid
- Product NDC
- 83270-451
- Requested package NDC
- 83270-451-05
- 11-digit product format
- 832700451
- Labeler code
- 83270
- Product ID
- 83270-451_5b089f5a-a845-264e-e063-6294a90ae52a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ETOPOSIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Onesource Specialty Pharma Limited
- Application
- NDA019557
- Marketing category
- NDA
- Marketing start
- 2026-05-29
- Substance
- ETOPOSIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019557-001 | VEPESID | ETOPOSIDE | 50MG | CAPSULE / ORAL | AB | RLD | 1986-12-30 |
| N019557-002 | VEPESID | ETOPOSIDE | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N019557-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | AB | RLD | 1986-12-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | AB | RLD | 1986-12-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | AB | RLD | 1986-12-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N019557-001 | VEPESID | 50MG | CAPSULE / ORAL | RLD | 1986-12-30 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N019557-002 | VEPESID | 100MG | CAPSULE / ORAL | RLD | 1986-12-30 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N019557-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N019557-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N019557-001 | AB | 1 | 011fe1cb6892… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N019557-001 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- VePesid
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ETOPOSIDE | 50 mg/1 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2ab98334-79be-46be-f4f5-d4a6cc04219e | Product name | 3 | 20180118 |
| 4896aaa2-df52-a28b-a484-cf928e9408ca | Product name | 1 | 20140508 |
| e9a73b62-e9c6-118b-a3be-022705d13855 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83270-451-05 | ETOPOSIDE | 20 in 1 CARTON | CAPSULE | 20 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ETOPOSIDE | ETOPOSIDE | Onesource Specialty Pharma Limited | 7bc994df-ee84-4ed7-80fa-737f70918953 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 019557 NDA019557 83270-451-05 83270-451 83270045105 |
| VePesid | ETOPOSIDE | Amneal Pharmaceuticals NY LLC | 2a40f3ed-4a36-4616-af6c-b616140fd5ee | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | 019557 NDA019557 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197687 | etoposide 50 MG Oral Capsule | PSN | 7bc994df-ee84-4ed7-80fa-737f70918953 | 1 |
| 197687 | etoposide 50 MG Oral Capsule | SCD | 7bc994df-ee84-4ed7-80fa-737f70918953 | 1 |
| 197687 | VP-16 50 MG Oral Capsule | SY | 7bc994df-ee84-4ed7-80fa-737f70918953 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 83270-451-05 | 83270045105 | 20 CAPSULE in 1 CARTON (83270-451-05) | 20 capsule | 2026-05-29 | No | No | Current |